Etrasimod is a synthetic sphingosine-1-phosphate (S1P) receptor modulator indicated for the treatment of moderate to severely active ulcerative colitis in adults. The Etrasimod category encompasses a wide… Read more

![Chemical structure of (R)-2-(7-((4-Cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)-N,N-dimethylacetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FR-2-7-4-Cyclopentyl-3-trifluoromethylbenzyloxy-1234-tetrahydrocyclopentabindol-3-yl-NN-dimethylacetamide.png&w=3840&q=75)
![Chemical structure of (R)-2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)-N-methylacetamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2863532-89-0-R-2-7-4-cyclopentyl-3-trifluoromethylbenzyloxy-1234-tetrahydrocyclopentabindol-3-yl-N-methylacetamide.png&w=3840&q=75)


![Chemical structure of 2-(8-((4-Cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-2,6-dioxo-1,2,3,4,5,6-hexahydrobenzo[b]azocin-3-yl)acetic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-8-4-Cyclopentyl-3-trifluoromethylbenzyloxy-26-dioxo-123456-hexahydrobenzobazocin-3-ylacetic-Acid.png&w=3840&q=75)


![Chemical structure of 7-((4-Cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-5a-hydroxy-3,3a,4,5,5a,10-hexahydro-2H-furo[2',3':1,5]cyclopenta[1,2-b]indol-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7-4-Cyclopentyl-3-trifluoromethylbenzyloxy-5a-hydroxy-33a455a10-hexahydro-2H-furo2315cyclopenta12-bindol-2-one.png&w=3840&q=75)

![Chemical structure of Ethyl 2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1206124-34-6-Ethyl-2-7-4-cyclopentyl-3-trifluoromethylbenzyloxy-1234-tetrahydrocyclopentabindol-3-ylacetate.png&w=3840&q=75)
![Chemical structure of Ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1206124-13-1-Ethyl-2-7-hydroxy-1234-tetrahydrocyclopentabindol-3-ylacetate.png&w=3840&q=75)



Etrasimod is a synthetic sphingosine-1-phosphate (S1P) receptor modulator indicated for the treatment of moderate to severely active ulcerative colitis in adults. The Etrasimod category encompasses a wide range of analytical tools necessary for pharmaceutical research and quality assurance, including reference standards of the active drug, its related impurities, synthetic intermediates, and metabolites. Pharmaceutical laboratories rely on these high-quality materials for impurity profiling, allowing for the precise identification and quantification of process-related impurities and degradation products. Furthermore, the inclusion of stable isotope-labelled versions of Etrasimod supports complex pharmacokinetic studies and metabolic profiling by providing reliable internal standards for mass spectrometry-based assays. These reference materials are fundamental to robust method validation, ensuring consistent quality control and regulatory compliance throughout the drug development lifecycle. By utilizing these characterized reference standards, analytical scientists can maintain high precision and accuracy in their testing procedures.